Aqua-Spark backs new technology
AQUACULTURE investor Aqua-Spark announced backing for two cutting edge technology companies that aim to make fish farming healthier and more efficient by eliminating antibiotics, reducing feed, and enabling farms to safeguard their broodstock.
Proteon is transforming bacteriophages, or ‘phages’, found in nature into commercial grade products that target bacterial infections in a way that doesn’t create resistance.
The company has two main products on the market: a solution against pseudomonas and aeromonas infections in fish and a solution against salmonella infections in poultry.
Meanwhile, another company, Cryoocyte, has developed high-precision fish farming technology to bring greater control and accuracy to fish breeding.
Through technology for low temperature preservation of unfertilised eggs, Cryoocyte allows more time to assess genetic material before mating decisions must be made.
New data on egg quality, presence of disease, and parental DNA helps Cryoocyte’s customers make more precise male-female mating decisions and produce naturally healthier offspring.
With these investments, Aqua-Spark said it has entered new areas of the value chain where there is potential to dramatically improve the industry overall.